Author： Bagnato Francesca Pozzilli Carlo
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.7, 2003-07, pp. : 1153-1163
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharmacological Treatment of Early Multiple Sclerosis
By Stüve Olaf Bennett Jeffrey L. Hemmer Bernhard
Drugs, Vol. 68, Iss. 1, 2008-01 ,pp. :
Access to resources
Recommend
Interferon-β1b in the treatment of multiple sclerosis
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. :
IFN-&bgr; pharmacogenomics in multiple sclerosis
By Vandenbroeck Koen Urcelay Elena Comabella Manuel
Pharmacogenomics, Vol. 11, Iss. 8, 2010-08 ,pp. :
By O’’Doherty Catherine Favorov Alexander Heggarty Shirley Graham Colin Favorova Olga Ochs Michael Hawkins Stanley Hutchinson Michael O’’Rourke Killian Vandenbroeck Koen
Pharmacogenomics, Vol. 10, Iss. 7, 2009-07 ,pp. :